Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Axios on your phone

Get breaking news and scoops on the go with the Axios app.

Download for free.

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!
Expand chart
Note: This map represents the total number of vaccines administered, not people vaccinated; Data: Our World in Data; Map: Danielle Alberti/Axios

The world has now crossed 1 billion total vaccines administered.

Breaking it down: Nearly half of those have come in the U.S. (29%), EU (13%) and U.K. (5%), with other rich countries also sprinting ahead. Another 22% have come in China and 14% in India. Africa, meanwhile, represents just 1.6% of vaccinations to date.

One reason is that the COVAX initiative, designed to ensure that every country has access to vaccines, is just 16% of the way to its distribution target for the first half of 2021.

  • That's due in large part to the fact that India — by far the largest provider of COVAX doses — went from exporting 77% of its production before March 15 to 7% over the past month, per Airfinity. India has curbed exports to fight the surge at home.
  • If India continues to keep nearly all of its production, Airfinity projects there would be enough supply to cover people over 60 by May and the entire adult population by November.
  • But African CDC Director John Nkengasong and other public health officials have called on India to lift the export restrictions, noting that a prolonged delay could be catastrophic for countries that are counting on COVAX.

What to watch: The main issue facing COVAX right now isn’t funding but securing reliable sources of vaccines.

  • It remains to be seen whether the U.S. will share the 60 million AstraZeneca doses it plans to export through COVAX or bilateral arrangements with individual countries.

Go deeper: Biden's move to share vaccine doses could be a global game changer

Go deeper

Updated Apr 26, 2021 - World

U.S. to send India supplies as country faces record COVID surge

Family members transport a COVID-19 patient on a stretcher as they leave a hospital in New Delhi on April 24. India surpassed the U.S. daily cases record on April 22. Photo: Sajjad Hussain/AFP via Getty Images

The Biden administration has pledged to send vital resources and supplies to India, as the country set a new global daily COVID-19 cases record for a fifth straight day Monday.

The big picture: As hospitals continued to be overwhelmed with coronavirus patients amid a widespread oxygen shortage, India's health ministry reported 352,991 more infections, taking the total past 17 million. A record 2,812 deaths were confirmed Monday, taking the total to 195,123 since the pandemic began.

Apr 26, 2021 - Health

Sanofi to manufacture 200 million Moderna COVID vaccines in U.S.

Photo: Ty O'Neil/SOPA Images/LightRocket via Getty Images

Sanofi announced Monday it will manufacture up to 200 million doses of Moderna's COVID-19 vaccine at its site in Ridgefield, New Jersey, from September.

Why it matters: The agreement between Sanofi and Moderna should not only boost the U.S. coronavirus vaccine rollout, it should also help global efforts as the doses will likely be exported.

Apr 26, 2021 - World

European Commission sues AstraZeneca for vaccine shortages

Photo: Thierry Monasse/Getty Images

The European Commission has launched legal proceedings against AstraZeneca for providing only a third of the supply of coronavirus vaccines agreed to in its contract, a spokesperson confirmed Monday.

Why it matters: It's the latest in a string of controversies related to the European Union's vaccine rollout, which has been plagued by supply shortages, a slow pace of distribution, and concerns about potential rare blood clots linked to AstraZeneca and Johnson & Johnson.

You’ve caught up. Now what?

Sign up for Mike Allen’s daily Axios AM and PM newsletters to get smarter, faster on the news that matters.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!